Showing results (1271-1280 of 3,351) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|June 17, 2003
The comparative medical costs of atherothrombotic disease in European countriesEmile Levy, Sylvie Gabriel, Jérôme DinetPharmacoeconomics|June 17, 2003
Economic evaluation of norethisterone acetate/ethinylestradiol (FemHRT) for women with menopausal symptomsDouglas Coyle, Ann Cranney, Peter TugwellPharmacoeconomics|June 17, 2003
Direct treatment costs for patients with lung cancer from first recurrence to death in franceAnne-Chantal Braud, Christine Lévy-Piedbois, Pascal Piedbois, et al.Pharmacoeconomics|March 12, 2003
Cost effectiveness of alendronate (fosamax) for the treatment of osteoporosis and prevention of fracturesOlof Johnell, Bengt Jönsson, Linus Jönsson, et al.Pharmacoeconomics|March 12, 2003
Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's diseaseAnders Wimo, Bengt Winblad, Albrecht Stöffler, et al.Pharmacoeconomics|March 12, 2003
Cost effectiveness of nasal budesonide versus surgical treatment for nasal polypsFredrik Berggren, Leif JohanssonPharmacoeconomics|March 12, 2003
Factors affecting UK primary-care costs of managing patients with asthma over 5 yearsRoben Dasgupta, Julian F GuestPharmacoeconomics|April 17, 2003
Economic evaluation of orlistat in overweight and obese patients with type 2 diabetes mellitusAndreas Maetzel, Jörg Ruof, Melva Covington, et al.Pharmacoeconomics|April 17, 2003
A stochastic economic evaluation of letrozole versus tamoxifen as a first-line hormonal therapy: for advanced breast cancer in postmenopausal patientsJon Karnon, Trefor JonesPharmacoeconomics|January 18, 2008
Having your cake and eating it: office of fair trading proposal for funding new drugs to benefit patients and innovative companiesBrian Godman, Alan Haycox, Ulrich Schwabe, et al.Pageof 336